Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study - Poll - MDSpire

Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study

  • By

  • Philipp Krausewitz

  • Dorothea Fostitsch

  • Richard Weiten

  • Niklas Kluemper

  • Johannes Stein

  • Julian Luetkens

  • Glen Kristiansen

  • Jörg Ellinger

  • Manuel Ritter

  • December 7, 2022

  • 0 min

Share

Original Source(s)

Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study

  • by Philipp Krausewitz, Dorothea Fostitsch, Richard Weiten, Niklas Kluemper, Johannes Stein, Julian Luetkens, Glen Kristiansen, Jörg Ellinger, Manuel Ritter

  • December 7, 2022

Related Content

Does non-visible haematuria require urgent assessment? A retrospective cohort study from a university teaching hospital

Retrospective comparison of direct in-bore magnetic resonance imaging (MRI)-guided biopsy and fusion-guided biopsy in patients with MRI lesions which are likely or highly likely to be clinically significant prostate cancer

Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?